ULTRAVIOLET B-EXPOSED MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II POSITIVE KERATINOCYTES AND ANTIGEN-PRESENTING CELLS DEMONSTRATE A DIFFERENTIAL CAPACITY TO ACTIVATE T-CELLS IN THE PRESENCE OF STAPHYLOCOCCAL SUPERANTIGENS
L. Skov et O. Baadsgaard, ULTRAVIOLET B-EXPOSED MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II POSITIVE KERATINOCYTES AND ANTIGEN-PRESENTING CELLS DEMONSTRATE A DIFFERENTIAL CAPACITY TO ACTIVATE T-CELLS IN THE PRESENCE OF STAPHYLOCOCCAL SUPERANTIGENS, British journal of dermatology, 134(5), 1996, pp. 824-830
In this study we tested the capacity of ultraviolet B (UVB)-irradiated
major histocompatibility complex (MHC) class II+ keratinocytes, monoc
ytes and dendritic cells to activate T cells in the presence of Staphy
lococcus enterotoxin B, We demonstrated that UVB irradiation of MHC cl
ass II+ keratinocytes does not change their capacity to activate T cel
ls in the presence of Staphylococcus enterotoxin B. In contrast, UVB i
rradiation of antigen-presenting cells decreases their capacity to act
ivate T cells. This differential capacity to activate T cells after UV
B irradiation was not due to factors released from UVB-irradiated cell
s, The interferon-gamma induced upregulation of HLA-DR and intercellul
ar adhesion molecule-1 on keratinocytes does not seem to be the only e
xplanation, since UVB irradiation decreased the accessory cell functio
n of interferon-gamma pretreated monocytes. Differential requirements
for and UVB regulation of costimulatory molecules map be involved, sin
ce blocking of the B7/CD28 pathway affects the capacity of dendritic c
ells but not keratinocytes to activate T cells in the presence of Stap
hylococcus enterotoxin B, Thus, MHC class II+ keratinocytes in the pre
sence of superantigens released from staphylococci may activate T cell
s and maintain inflammation despite UVB treatment.